SF3B1 and B-cell chronic lymphocytic leukemia: Although the functional impact of this alteration in CLL pathogenesis remains still ill-defined, its relevance is highlighted by the evidence that SF3B1-mutated patients show more aggressive disease and shorter survival than unmutated ones.